Mycobacterium avium complex pulmonary disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients with Mycobacterium avium complex pulmonary disease met the criteria advocated by the American Thoracic Society 1997 2)Patients who can visit the hospital regularly for 5 years or more 3)Signed agreement to participate in the study
Exclusion criteria
Exclusion criteria: 1)Patients known to be seropositive for human immunodeficiency virus 2)Judged inadequate to participate in the study by their physicians
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Relationship between the outcomes of multidrug chemotherapy and long-term survival prognosis 2)Search for useful prognostic predictors | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation as prognostic factors the following: 1) clinical characteristics 2) chest radiographic findings 3) results of sputum smear-culture examinations for acid-fast bacteria, and serobar 4) results of blood examinations (especially serum antibodies against acid-fast bacteria) | — |
Countries
Japan
Contacts
Graduate School of Medical Safety Management, Jikei University of Health Care Sciences Graduate school